Teva to Present at the Canaccord Genuity 33rd Annual Growth Conference
Canaccord Genuity Global Growth Conference 2013
JERUSALEM -- August 13, 2013
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio
webcast at the Canaccord Genuity 33^rd Annual Growth Conference in Boston,
Massachusetts. Dr. Jeremy M. Levin, President & CEO, will present on
Wednesday, August 14, 2013 at 9:30 AM ET.
What: Teva Presentation at the Canaccord Genuity 33^rd Annual Growth
Who: Dr. Jeremy M. Levin, President & CEO, Teva Pharmaceutical
When: Wednesday, August 14, 2013
Live over the Internet – log on to the Web at the address above and
How: register for the event (approximately 10 minutes before). An
archive of the webcast will be available on Teva’s website.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $20.3 billion in net revenues in 2012.
Teva Pharmaceutical Industries Ltd.
Kevin C. Mannix, 215-591-8912
Tomer Amitai, 972 (3) 926-7656
Iris Beck Codner, 972 (3) 926-7246
Denise Bradley, 215-591-8974
Press spacebar to pause and continue. Press esc to stop.